All research
2026-06-14 PubMed

Yinxie Granules (YXKL) and its flavonoids Quercetin/Kaempferol alleviate psoriasis by blocking STING-NF-κB pathway

Dual targeting of cutaneous inflammation and vasculopathy via STING-NF-κB blockade underlies the anti-psoriatic efficacy of Yinxie Granules.

Background

Psoriasis is a chronic inflammatory skin disease characterized by immune dysregulation and abnormal blood vessel formation. Current treatments often have limitations, and the precise mechanisms of many traditional remedies remain unclear. The STING (Stimulator of Interferon Genes) pathway is a crucial mediator of innate immunity and inflammation, increasingly implicated in inflammatory diseases. Understanding how compounds modulate STING could offer novel therapeutic avenues for psoriasis, addressing both inflammation and vasculopathy.

Study Design

Researchers investigated the anti-psoriatic mechanisms of Yinxie Granules (YXKL) using patient samples, IMQ-induced psoriatic mice, zebrafish models, and in vitro assays. The study focused on YXKL's effects on skin inflammation, barrier function, and specific signaling pathways. They aimed to identify the active components within YXKL responsible for its therapeutic effects and characterize their molecular targets. Assays included analysis of macrophage/Th17 infiltration, pro-inflammatory cytokine levels via ELISA, loricrin expression, and STING pathway activation.

Results

YXKL significantly alleviated skin inflammation and restored the skin barrier. This was achieved by reducing M1 macrophage and Th17 infiltration, lowering pro-inflammatory cytokines such as IL-6, IFN-β, IL-23, and IL-17, and increasing loricrin expression. Mechanistically, a dynamic transition in STING signaling was observed during psoriasis progression: both STING/IRF3 and STING/NF-κB pathways were activated in moderate disease, but only STING/NF-κB was hyperactivated in severe psoriasis. YXKL specifically targeted the STING/NF-κB pathway to mitigate inflammation and vasculopathy, without impacting upstream regulators like TRAF6, LKB1, AMPK, or ULK1.

Quercetin and kaempferol were identified as the primary STING-modulating components in YXKL, directly binding to STING proteins and inhibiting downstream pathway activation. These flavonoids suppressed skin inflammation and angiogenesis while enhancing vascular integrity through STING inhibition in both keratinocytes and endothelial cells.

Key Findings

  • YXKL alleviated skin inflammation and restored barrier function by reducing M1 macrophage/Th17 infiltration.
  • YXKL lowered pro-inflammatory cytokines (IL-6, IFN-β, IL-23, IL-17) and increased loricrin expression.
  • Psoriasis progression involved a shift from STING/IRF3 and STING/NF-κB activation to hyperactivated STING/NF-κB in severe disease.
  • YXKL specifically targeted and inhibited the STING/NF-κB pathway to mitigate inflammation and vasculopathy.
  • Quercetin and kaempferol were identified as active components, binding STING and inhibiting its downstream activation.

Why It Matters

This research provides a molecular basis for the clinical efficacy of Yinxie Granules (YXKL) in psoriasis, highlighting STING/NF-κB as a pivotal therapeutic target. Identifying Quercetin and Kaempferol as active STING inhibitors offers natural candidate compounds for developing new psoriasis treatments, potentially reducing reliance on systemic immunosuppressants or biologics. This could lead to more targeted, natural-product-derived therapies that address both inflammatory and vascular aspects of psoriasis, offering a novel approach for patients seeking alternative or complementary options.


psoriasis yinxie granules quercetin kaempferol sting nf-kb
Source: pubmed:42285688 · Ingested 2026-06-14 · Digest: gemini-2.5-flash